Consensus VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Market Closed - Nasdaq 04:00:00 2023-11-27 pm EST Intraday chart for VYNE Therapeutics Inc. 5-day change 1st Jan Change
3.970 USD -1.00% +0.51% +47.04%

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.970USD
Average target price
5.583USD
Spread / Average Target
+40.64%
High Price Target
6.000USD
Spread / Highest target
+51.13%
Low Price Target
5.000USD
Spread / Lowest Target
+25.94%

Consensus detail

Consensus revision (last 18 months)

Analysts covering VYNE Therapeutics Inc.

Cantor Fitzgerald
HC Wainwright
Northland Securities
Trading Rating :
Investor Rating :
ESG Refinitiv :
C-
More Ratings
-40% off Black Friday : Our subscriptions help you unlock the best investment opportunities.
Enjoy this offer